Day: February 7, 2024

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy

Staff February 7, 2024

MINNEAPOLIS, MN, US, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo")...

Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer

Staff February 7, 2024

Jean Franchi is an industry veteran and brings over 30 years of leadership experience in finance, investor relations, capital formation,...

Stryker declares a $0.80 per share quarterly dividend

Staff February 7, 2024

Portage, Michigan, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly...

Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.

Staff February 7, 2024

TAMPA, Fla., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc., (Nasdaq: PCRX), the industry leader in its commitment to...

Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Staff February 7, 2024

DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines...

Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

Staff February 7, 2024

BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...

Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma

Staff February 7, 2024

The independent data monitoring committee (IDMC) recommended the continuation of VIRAGE with no safety concerns raised; VIRAGE remains on track...

Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method

Staff February 7, 2024

Nes-Ziona, Israel, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...

New Survey Highlights Dire State of Nursing in 2024, Finds Optimism from Nurses Still in Profession

Staff February 7, 2024

IntelyCare's nationwide survey of nurses and nursing assistants points to workload, safety, care quality, and other concernsQUINCY, Mass., Feb. 07,...

One month left to submit a claim under the First Nations Drinking Water Settlement

Staff February 7, 2024

TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Eligible First Nations communities and individuals have until March 7, 2024, to submit...

Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts

Staff February 7, 2024

Daxor's ezBVA Lab Service Plays a Significant Role in Driving Growth and Fostering Widespread Adoption Oak Ridge, TN, Feb. 07,...

Day: February 7, 2024

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy

Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer

Stryker declares a $0.80 per share quarterly dividend

Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.

Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma

Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method

New Survey Highlights Dire State of Nursing in 2024, Finds Optimism from Nurses Still in Profession

One month left to submit a claim under the First Nations Drinking Water Settlement

Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts

Skye Bioscience to Present at Oppenheimer Investor Conference

Groundbreaking Digital Health Platform Set to Transform Healthcare in the UK

V&P Scientific Partners With Bioz to Provide Researchers With Validated Product Insights

Perimed AB Partners with Serendipity Partners to Accelerate Growth and Innovation

Spago Nanomedical Year-end Report January-December, 2023

IRLAB Publishes Year-end Report for the Period January-December 2023

Medical Equipment Maintenance Market: Forecasted USD 88.9 Billion by 2029, CAGR 10.5% | MarketsandMarkets™

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform

Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)

Senator Jon Ossoff and Vision to Learn Founder Austin Beutner Address National Vision Care Crisis Among School Children

Avinger Announces Pricing of up to $24 Million Public Offering

You may have missed